111 related articles for article (PubMed ID: 35527272)
1. Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions.
Yoon SM; Bazan JG
Curr Oncol Rep; 2024 Apr; ():. PubMed ID: 38652425
[TBL] [Abstract][Full Text] [Related]
2. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Kroese TE; Bronzwaer S; van Rossum PSN; Schoppman SF; Deseyne PRAJ; van Cutsem E; Haustermans K; Nafteux P; Thomas M; Obermannova R; Mortensen HR; Nordsmark M; Pfeiffer P; Elme A; Adenis A; Piessen G; Bruns CJ; Lordick F; Gockel I; Moehler M; Gani C; Liakakos T; Reynolds JV; Morganti AG; Rosati R; Castoro C; Cellini F; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; van Berge Henegouwen MI; Hulshoff MCCM; van Dieren J; Vollebergh M; van Sandick JW; Jeene P; Muijs C; Slingerland M; Voncken FEM; Hartgrink H; Creemers GJ; van der Sangen MJC; Nieuwenhuijzen GAP; Berbee M; Verheij M; Wijnhoven B; Beerepoot LV; Mohammad NH; Mook S; Ruurda JP; Kolodziejczyk P; Polkowski WP; Wyrwicz L; Alsina M; Tabernero J; Pera M; Kanonnikoff TF; Cervantes A; Nilsson M; Monig S; Wagner AD; Guckenberger M; Griffiths EA; Smyth E; Hanna GB; Markar S; Chaudry MA; Hawkins MA; Cheong E; van Laarhoven HWM; van Hillegersberg R;
Eur J Cancer; 2024 Jun; 204():114062. PubMed ID: 38678762
[TBL] [Abstract][Full Text] [Related]
3. Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time.
Averbuch I; Moore A; Ludmir EB; Markel G; Meirson T
Br J Cancer; 2024 May; ():. PubMed ID: 38710837
[TBL] [Abstract][Full Text] [Related]
4. Oligometastatic Breast Cancer: How to Manage It?
Barberi V; Pietragalla A; Franceschini G; Marazzi F; Paris I; Cognetti F; Masetti R; Scambia G; Fabi A
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207648
[TBL] [Abstract][Full Text] [Related]
5. Local treatment in oligometastasis from breast cancer: an overview.
Burgaleta AM; Burguete AB; Gutiérrez LR; Nuín EB; Felipe GA; de la Vega FA
Clin Transl Oncol; 2023 Oct; 25(10):2861-2867. PubMed ID: 37106239
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic Breast Cancer.
Strauss JB; Chmura SJ
Semin Radiat Oncol; 2022 Jul; 32(3):282-290. PubMed ID: 35688526
[TBL] [Abstract][Full Text] [Related]
7. Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.
Olson R; Jiang W; Liu M; Bergman A; Schellenberg D; Mou B; Alexander A; Carolan H; Hsu F; Miller S; Atrchian S; Chan E; Ho C; Mohamed I; Lin A; Berrang T; Bang A; Chng N; Matthews Q; Baker S; Huang V; Mestrovic A; Hyde D; Lund C; Pai H; Valev B; Lefresene S; Tyldesley S
JAMA Oncol; 2022 Nov; 8(11):1644-1650. PubMed ID: 36173619
[TBL] [Abstract][Full Text] [Related]
8. Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?
Miglietta F; Visani L; Marini S; Griguolo G; Vernaci GM; Bottosso M; Dieci MV; Meattini I; Guarneri V
Cancer Treat Rev; 2022 Nov; 110():102462. PubMed ID: 36087503
[TBL] [Abstract][Full Text] [Related]
9. A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group.
Marvaso G; Mastroleo F; Corrao G; Zaffaroni M; Vincini MG; Borghetti P; Cuccia F; Federico M; Montesi G; Pontoriero A; Franceschini D; Franzese C; Scorsetti M; Jereczek-Fossa BA
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568718
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy concepts for spinal metastases-results from an online survey among radiation oncologists of the German Society for Radiation Oncology.
Waltenberger M; Vogel MME; Bernhardt D; Münch S; Dobiasch S; Redmond KJ; Lo SS; Acker G; Fehlings MG; Ringel F; Vajkoczy P; Meyer B; Combs SE
Strahlenther Onkol; 2024 Feb; 200(2):159-174. PubMed ID: 37272996
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Lacaze JL; Chira C; Glemarec G; Monselet N; Cassou-Mounat T; De Maio E; Jouve E; Massabeau C; Brac de la Perrière C; Selmes G; Ung M; Nicolai V; Cabarrou B; Dalenc F
Breast Cancer Res Treat; 2023 Apr; 198(3):463-474. PubMed ID: 36790573
[TBL] [Abstract][Full Text] [Related]
12. Special Techniques of Adjuvant Breast Carcinoma Radiotherapy.
Kolářová I; Melichar B; Vaňásek J; Sirák I; Petera J; Horáčková K; Pohanková D; Šinkorová Z; Hošek O; Vošmik M
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612294
[TBL] [Abstract][Full Text] [Related]
13. Physical and nonphysical effects of weekly music therapy intervention on the condition of radiooncology patients.
Clemens P; Szeverinski P; Tschann P; Dietl M; Gurk J; Kowatsch M; Tucek G; de Vries A
Strahlenther Onkol; 2023 Mar; 199(3):268-277. PubMed ID: 36564569
[TBL] [Abstract][Full Text] [Related]
14. Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective.
Piroth MD; Krug D; Feyer P; Baumann R; Combs S; Duma MN; Dunst J; Fastner G; Fietkau R; Guckenberger M; Haase W; Harms W; Hehr T; Sedlmayer F; Souchon R; Strnad V; Budach W
Strahlenther Onkol; 2022 Jul; 198(7):601-611. PubMed ID: 35527272
[TBL] [Abstract][Full Text] [Related]
15. A review of ongoing trials of stereotactic ablative radiotherapy for oligometastatic disease in the context of new consensus definitions.
Li GJ; Arifin AJ; Al-Shafa F; Cheung P; Rodrigues GB; Palma DA; Louie AV
Ann Palliat Med; 2021 May; 10(5):6045-6051. PubMed ID: 32787370
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study.
Willmann J; Vlaskou Badra E; Adilovic S; Ahmadsei M; Christ SM; van Timmeren JE; Kroeze SGC; Mayinger M; Guckenberger M; Andratschke N
Radiother Oncol; 2022 Mar; 168():256-264. PubMed ID: 35101466
[TBL] [Abstract][Full Text] [Related]
17. Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer.
Weykamp F; König L; Seidensaal K; Forster T; Hoegen P; Akbaba S; Mende S; Welte SE; Deutsch TM; Schneeweiss A; Debus J; Hörner-Rieber J
Front Oncol; 2020; 10():987. PubMed ID: 32676455
[No Abstract] [Full Text] [Related]
18. Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis.
Chen X; Chen H; Poon I; Erler D; Badellino S; Biswas T; Dagan R; Foote M; Louie AV; Ricardi U; Sahgal A; Redmond KJ
Cancer Med; 2021 Sep; 10(18):6189-6198. PubMed ID: 34432390
[TBL] [Abstract][Full Text] [Related]
19. Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials.
Izmailov T; Ryzhkin S; Borshchev G; Boichuk S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958408
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
